HIV inhibiting 1,2,4-triazines
US7585861B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2004 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Feb 5, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D253/075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to HIV replication inhibitors of formula (I) as defined in the specification their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.